Navigation Links
Isolagen, Inc. Reorganizes as Fibrocell Science, Inc.
Date:10/6/2009

lan Daly will continue to serve as chief operating officer (COO) and chief financial officer (CFO).

"We welcome our new Board members and value their contributions during this transformational time for the Company," said Declan Daly. "We have a major near-term company milestone this week when the FDA advisory committee will review azfibrocel-T, our lead investigational cell therapy for the treatment of nasolabial fold wrinkles. We look forward to gaining Committee input, and working with the FDA as we seek to bring this novel aesthetic therapy to the market in 2010."

BLA Review Underway; FDA Advisory Committee Scheduled

In May 2009, the FDA accepted for full review the BLA of azfibrocel-T for the treatment of moderate to severe nasolabial fold wrinkles. The Prescription Drug User Fee Act (PDUFA) target date for FDA response is January 4, 2010.

The azfibrocel-T pivotal Phase III safety and efficacy studies (IT-R-005; IT-R-006) evaluated a total of 421 individuals at 13 clinical sites across the United States. Study results demonstrated a significant difference in therapy results compared to placebo (p < 0.01). No serious adverse events were reported.

The Cellular, Tissue and Gene Therapies Advisory Committee Meeting will be held on October 9, 2009 in Bethesda, Maryland. Background materials for the meeting are expected to be made available by the FDA on www.fda.gov no later than two business days before the meeting.

About Azfibrocel-T

Azfibrocel-T, proposed brand name Laviv(TM), is an investigational autologous cell therapy. In the Fibrocell Science patented process, a patient's own natural fibroblasts are extracted, multiplied and re-injected as personalized therapy. Fibroblasts are cells which contribute to the formation of connective tissue fibers. The therapy is currently under review by the FDA for the treatment of nasolabial
'/>"/>

SOURCE Fibrocell Science, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related biology technology :

1. Isolagen, Inc. Announces Receipt of Interim Order from Bankruptcy Court Approving DIP Motion
2. Isolagen, Inc. Receives Notification Letter from Amex
3. Isolagen, Inc. Reports Results of Shareholders Annual Meeting
4. ADM Reorganizes Operations
5. California Life Science, Business, and Economic Development Experts Discuss Californias Bioscience Future
6. FRC: NIH Stem Cell Guidelines Reflect Poor Science, Ignore Real Hope for Patients
7. Seahorse Bioscience, Inc. Acquires BioProcessors Corp.
8. Bert W. OMalley, M.D., Recipient of the 2008 National Medal for Science, Joins Bionovos Scientific Advisory Board
9. For creating new field of science, Texas chemist wins international prize
10. Todd R. Nelson Named Chief Executive Officer of eBioscience, Inc.
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... delivery of Brookfield Engineering’s Powder Flow Tester – helping Brookfield ... smaller footprint and more compact design. , ... ... a US-based thermoforming company, has completed the delivery of Brookfield ... metal to a plastic enclosure with a smaller footprint and ...
(Date:12/11/2009)... Dendreon Corporation (Nasdaq: DNDN ) ... announced public offering have exercised in full their ... common stock at the public offering price of ... option increases the size of the offering to ... Dendreon expects to receive net proceeds from ...
(Date:12/11/2009)... College researchers have observed the "hot electron" effect in ... harvested the elusive charges using ultra-thin solar cells, opening ... authors report in the current online edition of ... in solar cells, it generates free electrons in a ... these charges, the electrons must reach the bottom of ...
(Date:12/11/2009)... -- Marrone Bio Innovations (MBI) today announces 2 ... Chris Hildreth joined MBI as Senior Vice President ... all commercial aspects of the company, including sales, ... (Ray) Lam joined MBI as Vice President of ... in scaling its broad pipeline of products to ...
Breaking Biology Technology:Thermofab Helps Brookfield Engineering Move To A Compact Custom Plastic Enclosure 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 2Dendreon Announces Exercise of Option by Underwriters in its Common Stock Offering 3Elusive 'hot' electrons captured in ultra-thin solar cells 2Marrone Bio Innovations Announces Two New Executive Appointments 2Marrone Bio Innovations Announces Two New Executive Appointments 3
... to ... 66.3% - Company Prepares to Launch Newest Generation of Laser Lipolysis ... Technology, WESTFORD, Mass., ... array of,light-based aesthetic treatment systems, today announced record revenues,and gross margin for the quarter ended March ...
... released a collection of important papers addressing a ... and social implications. The anthology Nanotechnology and ... contentious issues as environmental impact, health dangers, medical ... international governance, and more. , The anthology features ...
... Dacogen Royalty Revenue Increases 114% from Same Prior Year ... SUPG ) today reported financial results for the ... the 2008 first quarter were $8.1 million, compared,with $4.4 ... for the,2008 first quarter consisted of $8.1 million in ...
Other Biology Technology:Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 2Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 3Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 4Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 5Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 6Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 7Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 8Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 9Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 10Cynosure Reports 41% Revenue Increase: 10th Consecutive Quarter of Revenue Growth 11Springer publishes anthology with the Nanoethics Group 2SuperGen Reports 2008 First Quarter Financial Results 2SuperGen Reports 2008 First Quarter Financial Results 3SuperGen Reports 2008 First Quarter Financial Results 4SuperGen Reports 2008 First Quarter Financial Results 5SuperGen Reports 2008 First Quarter Financial Results 6SuperGen Reports 2008 First Quarter Financial Results 7SuperGen Reports 2008 First Quarter Financial Results 8SuperGen Reports 2008 First Quarter Financial Results 9
(Date:12/15/2009)... as babies are born, they are susceptible to diseases ... to a month, their immune systems aren,t adequately developed ... they can lead to serious problems if left untreated. ... researchers have pinpointed a group of depleted white blood ... "We,re trying to improve the immune system of newborns ...
(Date:12/15/2009)... VIB and Ghent University in Flanders, Belgium have found ... the major cause of death in intensive care units. ... in mice with septic shock, researchers Anje Cauwels and ... less damage, while their chances of survival increased significantly. ... assumed that nitric oxide is responsible for the potentially ...
(Date:12/15/2009)... In the near future, consumers can look forward ... such as laptops, PDAs and mobile phones. This ... energy harvesting technologies which are critical elements for ... devices and systems. , Analog IC design is ... energy harvesting. To pre-position the nation in advanced ...
Breaking Biology News(10 mins):Researchers work on vaccine to improve immune system in newborns 2Septic shock: Nitric oxide beneficial after all 2NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 2NTU and EDB launch S$50 million ($36 million) integrated circuit design research center 3Bioheart Inc Announces Receipt of 242 8 Million in Proceeds From Pipe Financing 51264 1Bioheart Inc Announces Receipt of 242 8 Million in Proceeds From Pipe Financing 51264 2Bioheart Inc Announces Receipt of 242 8 Million in Proceeds From Pipe Financing 51264 3Blue Cross and Blue Shield of Illinois Awards 241 4 Million to 14 Community Initiatives in Chicago and Downstate 51262 1Blue Cross and Blue Shield of Illinois Awards 241 4 Million to 14 Community Initiatives in Chicago and Downstate 51262 2Oral body inflammatory connection explained 51261 1Oral body inflammatory connection explained 51261 2Oral body inflammatory connection explained 51261 3
... so-called Jekyll and Hyde bacteria, suggesting a novel way ... at the University of York studied the relationship between ... and discovered an unexpected interaction. , Plants are ... thrive on plant food only because of the presence ...
... For Immediate Release - A catalytic antibody discovery made ... of the upcoming acquisition of biotechnology venture CovX by ... that our scientific findings have found such a broad ... M.D., president of Scripps Research. "This development underlines the ...
... and vegetation allowed human ancestors to evolve in Africa. ... to the idea that ground movements formed mountains and ... , Tectonics [movement of Earths crust] was ultimately responsible ... of the universitys Energy and Geoscience Institute write in ...
Other Biology News:Scripps Research discovery leads to broad potential applications in CovX-Pfizer deal 2Scripps Research discovery leads to broad potential applications in CovX-Pfizer deal 3Scripps Research discovery leads to broad potential applications in CovX-Pfizer deal 4Scripps Research discovery leads to broad potential applications in CovX-Pfizer deal 5Evolution tied to Earth movement 2Evolution tied to Earth movement 3Evolution tied to Earth movement 4
Rabbit polyclonal antibody to NCOA2 [Agarose Immobilized]...
Monocarboxylate (lactate) transporter 2...
Mouse Anti-Human Kallikrein 2 (Hk2)...
... Asb-2 (Ankyrin repeat and SOCS box-containing protein) ... peptides containing amino acids 75-93 and 348-368 ... (Imgenex Catalog No. 40149) can be used ... react with mouse and rat Asb-2, based ...
Biology Products: